Skip to main content
Resource Library
Patel, N.R.
Approaches for Clinical Supply Modelling and Simulation
Creating Value With Financially Adaptive Clinical Trials
Impact of Phase 2b Strategies on Optimization of Drug Development Programs
Drug Development and the Cost of Capital
Dynamically Optimizing Budget Allocation for Phase 3 Drug Development Portfolios Incorporating Uncertainty in the Pipeline
Methodological Extensions of Phase 2 Trial Designs Based on Program-level Considerations: Further Development of a Case Study in Neuropathic Pain